Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
On average 39% of pharmacy spend comes from non-network dispensing channels.
At Genex, we've always been passionate about advancing the field of case management.
In this WCI-TV interview, Brian Allen, VP of Governmental Affairs, offers an update on top regulatory and legislative initiatives that could impact
In this WCI-TV interview, Enlyte’s Tammy Bradly, Senior Director, Clinical Product Marketing, shares why states are implementing new workers’ comp